Roberta Bondar, Canada’s first female astronaut and a neuro-ophthalmologist, has drawn attention to the overlapping biological and environmental hazards facing the Artemis II crew as NASA prepares for the first crewed flight test of its Orion spacecraft. Her commentary centers on two distinct threat categories: the headward fluid shifts that occur in microgravity and the acute radiation danger posed by solar storms during a mission that will carry astronauts beyond low-Earth orbit for the first time in more than five decades. With NASA and the Canadian Space Agency having assigned crew members to the mission, the practical question is whether current countermeasures can manage both risks simultaneously on a vehicle that has never carried humans.
What is verified so far
The strongest confirmed facts cluster around three areas: crew assignment, solar radiation planning, and fluid-shift science. NASA and the Canadian Space Agency formally announced the assignment of Artemis II astronauts, establishing the mission as the first crewed flight test of Orion on the path to a long-term lunar presence. That milestone gives Bondar’s warnings direct relevance: the crew will leave the protection of Earth’s magnetosphere and enter an environment where solar energetic particles pose a distinct acute risk.
On the radiation front, NASA has built a layered defense. The agency monitors solar activity before and during the launch window through two dedicated teams: the Moon to Mars Space Weather Analysis Office and the Space Radiation Analysis Group, known as SRAG. NOAA’s Space Weather Prediction Center provides direct decision support to SRAG, creating an interagency chain in which SWPC forecasts feed SRAG analysis, which then informs mission decisions. The primary hazard focus of that chain is significant solar radiation storms that could deliver high doses of energetic particles in a short period of time.
Inside Orion itself, engineers have designed a storm shelter that crew members can assemble from stowage bags, creating a dense barrier around them. The Hybrid Electronic Radiation Assessor, or HERA, serves as an onboard warning system for radiation events, and the potential shelter duration is up to 24 hours. An AstroRad radiation vest, developed with the Israel Space Agency and the German Aerospace Center (DLR), was tested during the uncrewed Artemis I mission and is designed to complement those shelter procedures by adding targeted shielding over particularly sensitive tissues.
On the biological side, NASA’s Glenn Research Center has published research establishing that headward fluid shift in microgravity is hypothesized to contribute to Spaceflight Associated Neuro-Ocular Syndrome, or SANS. A peer-reviewed paper in the MDPI journal Life describes how microgravity induces cephalad fluid shift leading to ophthalmic changes that were historically called Visual Impairment Intracranial Pressure syndrome, now reclassified as SANS. Bondar’s background as a neuro-ophthalmologist makes her particularly attuned to this risk, since vision impairment during a deep-space mission could compromise crew performance at critical moments.
NASA has also been steadily publishing new technical material on Artemis planning and human health in space. Its compilation of recently released documents includes mission updates, safety analyses, and research summaries that trace how the agency is translating long-standing microgravity concerns into operational guidelines for upcoming flights.
What remains uncertain
Several gaps separate the verified planning from full operational confidence. No primary source in the available reporting confirms specific SANS countermeasures tailored to the Artemis II crew. NASA’s computational modeling work at Glenn Research Center addresses the condition at a general level, but whether the agency has developed mission-specific protocols for fluid-shift monitoring during the approximately 10-day Artemis II flight profile is not documented in the public record reviewed here. Bondar’s commentary highlights the risk, yet no direct, on-the-record quotes from her specifying particular Artemis II vulnerabilities have been confirmed through primary institutional sources.
The integration between real-time SWPC forecasts and Orion’s onboard HERA instrument during actual flight conditions also lacks detailed public documentation. NOAA has described its 24/7 monitoring and warning role, and NASA has described HERA’s function, but how the two systems hand off data in practice during a crewed mission beyond Earth orbit has not been tested with humans aboard. Artemis II will be the first such test, meaning the interagency chain has been validated only through simulations and the uncrewed Artemis I flight.
There is also limited public information about how the Canadian Space Agency coordinates with NASA on crew health monitoring for its astronaut on the mission. The crew assignment advisory confirms Canada’s participation but does not detail bilateral medical protocols. Whether fluid-shift baselines were collected for individual crew members before assignment, or whether personalized SANS risk profiles exist, is not addressed in available institutional documents. In the absence of such detail, it remains unclear how much individual variability in SANS susceptibility is being factored into real-time medical decision-making during the flight.
Apollo-era solar events provide historical context for radiation protection planning, but the Sun’s behavior during Artemis II cannot be predicted with certainty. The current solar cycle has produced intense activity, and while forecasting has improved since the 1970s, the ability to give crew members enough warning to shelter remains bounded by the physics of solar energetic particle travel times. A large event during the narrow window when the crew is beyond the magnetosphere would test every layer of the defense system at once and could compress decision timelines to minutes.
How to read the evidence
The strongest evidence in this story comes from primary government sources on both sides of the risk equation. NASA’s own mission pages and NOAA’s operational statements describe concrete systems, named teams, and specific hardware. These are not speculative; they reflect institutional commitments backed by budgets and personnel. When NASA says SRAG will analyze SWPC forecasts and recommend shelter actions, that represents an accountable process with defined roles and escalation paths.
The fluid-shift science sits on a different evidentiary footing. The MDPI paper and related NASA work are clear that SANS is a recognized syndrome associated with long-duration exposure to microgravity, particularly on the International Space Station. However, the translation of that understanding to a shorter, roughly 10-day lunar flyby remains an extrapolation. The biological mechanisms(cephalad fluid shift, potential changes in intracranial pressure, and structural alterations in the eye)are established, but dose-response relationships for mission duration and individual susceptibility are not. Bondar’s concerns therefore rest on solid physiology but uncertain mission-specific risk probabilities.
Radiation planning, by contrast, benefits from both historical analogues and maturing operational infrastructure. Apollo missions traversed similar regions of space, and modern heliophysics has deepened understanding of solar particle events. The existence of dedicated teams, continuous monitoring, and an onboard detector such as HERA shows that NASA is treating radiation as a quantifiable, trackable hazard. Yet even here, the uncertainty in solar behavior and the rarity of extreme events mean that Artemis II will function as a live demonstration of systems that have so far been exercised mainly in models and uncrewed tests.
Another dimension to the evidence is how it is communicated to the public and expert communities. NASA has expanded its outreach through platforms such as NASA+, which packages mission briefings and technical explainers into streaming formats, and through a growing suite of audio programs that feature engineers, scientists, and astronauts discussing Artemis planning. These channels provide context and narrative but, by design, do not replace the granular technical documents and peer-reviewed studies that specialists use to assess risk.
For readers weighing Bondar’s warnings against NASA’s assurances, the most responsible interpretation is that both perspectives can be simultaneously valid. Bondar, drawing on her neuro-ophthalmology expertise, is emphasizing a class of risks, vision changes and neurological effects, that are biologically plausible and potentially mission-critical but not yet fully characterized for this specific flight profile. NASA, for its part, is emphasizing the systems it has in place to manage known hazards, particularly radiation, while acknowledging through its ongoing research and publications that knowledge gaps remain.
Ultimately, Artemis II will serve as a bridge between decades of low-Earth-orbit experience and the more demanding environment of lunar exploration. The mission’s success will not only be measured by whether Orion completes its trajectory and returns safely, but also by the quality of the data gathered on how human bodies and protective technologies perform together beyond the shield of Earth’s magnetosphere. Bondar’s focus on overlapping risks underscores that future deep-space missions will have to manage complex interactions between physiology and environment, rather than treating each hazard in isolation. How effectively Artemis II captures and shares that information will shape the safety architecture of lunar and Martian expeditions for years to come.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
